Boston Scientific to acquire BridgePoint Medical

qiangzi

Friday, September 21, 2012

4 s3 u. f6 _6 ]6 }3 B1 `Natick, MA - Boston Scientific has signed a definitive agreement to acquire BridgePoint Medical, Inc., a privately held company based in Minneapolis, MN. BridgePoint Medical has developed a proprietary, catheter-based system to treat coronary chronic total occlusions (CTOs). The transaction is expected to close in the fourth quarter of 2012 subject to customary closing conditions. The transaction is expected to have an immaterial impact on GAAP and adjusted earnings in 2012 and 2013 and be modestly accretive thereafter. Financial terms of the transaction are not being disclosed. -

gyzxdl

在线翻译，以供阅读。
纳提克，马萨诸塞州 - 波士顿科学公司已经签署了一项最终协议，收购BridgePoint医药公司是一家私人持有的公司，总部设在明尼苏达州明尼阿波利斯。 BridgePoint医疗已开发出一种专利，导管为基础的系统来治疗冠状动脉慢性完全闭塞病变（CTOS）。该交易预计将在第四季度，2012年受惯例成交条件。该交易预计在2012年和2013年，此后小幅增生，有一个无形的影响美国通用会计准则调整后的收益。该交易的财务条款没有披露。 -